Home Daily Stock Opinions and Ratings Stressgen Biotechnologies Corp (SSB-T)

Trending stocks today

Hammond Power Solutions Inc. Horizons High Interest Savings ETF Global X High Interest Savings ETF Enbridge Wajax Corp Chemtrade Logistics Income Fund Prospect Capital Hims & Hers Health Chevron Texaco Adyen NV Thermo Fisher Scientific Northland Power Inc BMO S&P US Mid Cap Index ETF Manulife Financial Netflix Inc. AtkinsRealis Group Pfizer Inc Meta Platforms, Inc.

Stressgen Biotechnologies Corp (SSB-T)

NEW AI Investor Insights
0 watching

0.00
0.00 (0.00%) 1d
0
DON'T BUY

Stressgen Biotechnologies Corp(SSB-T)

26/07/2005
Stressgen Biotechnologies Corp
A lottery ticket! The company has gone into orphan status. Have disappointed investors many, many times. They keep needing money. Very risky.
biotechnology / pharmaceutical
Peter Hodson
$0.370
No
UnlockRating
DON'T BUY

Stressgen Biotechnologies Corp(SSB-T)

12/11/2004
Stressgen Biotechnologies Corp
Trying to raise $50 million which is equivalent/more than their entire market cap.
biotechnology / pharmaceutical
Duncan Stewart
$0.440
No
UnlockRating
PAST TOP PICK

Stressgen Biotechnologies Corp(SSB-T)

09/11/2004
Stressgen Biotechnologies Corp
(A Top Pick June 14/04. Down 56%.) They continue to lose money. They'll have to get something through their pipeline quickly that deals with cancer. Doesn't look good.
biotechnology / pharmaceutical
Benj Gallander
$0.455
No
UnlockRating
TOP PICK

Stressgen Biotechnologies Corp(SSB-T)

15/06/2004
Stressgen Biotechnologies Corp
Holds this stock personally. Risky could double.
biotechnology / pharmaceutical
Benj Gallander
$1.060
Owned
UnlockRating
TRADE

Stressgen Biotechnologies Corp(SSB-T)

05/12/2003
Stressgen Biotechnologies Corp
A field that you have to be really wary of. Many of them have a very high burn rate. Although their trials were fast tracked, this does not necessarily mean continued success.
biotechnology / pharmaceutical
Benj Gallander
$1.930
No
UnlockRating
DON'T BUY

Stressgen Biotechnologies Corp(SSB-T)

04/12/2003
Stressgen Biotechnologies Corp
Have restructured and will need more money.
biotechnology / pharmaceutical
Peter Hodson
$2.130
No
UnlockRating
BUY

Stressgen Biotechnologies Corp(SSB-T)

07/10/2003
Stressgen Biotechnologies Corp
Very volatile. Developing a product for HBV (a sexually transmitted disease), which has a large market. In phase two. Has a partnership with Roach and has enough cash to probably last into 2005.
biotechnology / pharmaceutical
John Sinkins, CFA
$2.040
No
UnlockRating
DON'T BUY

Stressgen Biotechnologies Corp(SSB-T)

30/06/2003
Stressgen Biotechnologies Corp
On their watch list. Lost a lot of maney last year.
biotechnology / pharmaceutical
Benj Gallander
$1.710
No
UnlockRating
BUY ON WEAKNESS

Stressgen Biotechnologies Corp(SSB-T)

14/05/2003
Stressgen Biotechnologies Corp
A speculative stock. Has to move through the regulatory gateway. Meets a lot of technical resistance at the $1.81 level. Try to pick up near its support level of $1.25.
biotechnology / pharmaceutical
Lou Schizas
$1.780
Unknown
UnlockRating
BUY

Stressgen Biotechnologies Corp(SSB-T)

12/05/2003
Stressgen Biotechnologies Corp
They are far enough into their trials that investors are now paying more attention. Relatively cheap. Management is OK.
biotechnology / pharmaceutical
Peter Hodson
$1.900
Unknown
UnlockRating
BUY

Stressgen Biotechnologies Corp(SSB-T)

02/10/2002
Stressgen Biotechnologies Corp
Outlook is quite good and the price is at a good level.
biotechnology / pharmaceutical
Mike Weir
$2.450
Unknown
UnlockRating
BUY

Stressgen Biotechnologies Corp(SSB-T)

26/08/2002
Stressgen Biotechnologies Corp
At a good level. Has mad a good agreement with a large pharmaceutical.
biotechnology / pharmaceutical
Mike Weir
$3.250
Unknown
UnlockRating
WEAK BUY

Stressgen Biotechnologies Corp(SSB-T)

17/05/2002
Stressgen Biotechnologies Corp
In the final stage of their clinical trials. Will be a couple of years before you know if the product works.
biotechnology / pharmaceutical
Bruce Cooper
$4.500
Unknown
UnlockRating
WEAK BUY

Stressgen Biotechnologies Corp(SSB-T)

02/05/2002
Stressgen Biotechnologies Corp
Well along on the approval line. Product seems to be good. The sector is suffering. A higher risk.
biotechnology / pharmaceutical
Bruce Cooper
$3.530
Unknown
UnlockRating
WAIT

Stressgen Biotechnologies Corp(SSB-T)

15/01/2002
Stressgen Biotechnologies Corp
Fairly risky, but a good risk/reward ratio. In phase 3 trials. Could double if they get into a good partnership.
biotechnology / pharmaceutical
Bruce Cooper
$5.500
Unknown
UnlockRating
Showing 1 to 15 of 23 entries
Next PageNext Page

Stressgen Biotechnologies Corp(SSB-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Stressgen Biotechnologies Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Stressgen Biotechnologies Corp(SSB-T) Frequently Asked Questions

What is Stressgen Biotechnologies Corp stock symbol?

Stressgen Biotechnologies Corp is a OTC stock, trading under the symbol SSB-T on the (). It is usually referred to as or SSB-T

Is Stressgen Biotechnologies Corp a buy or a sell?

In the last year, there was no coverage of Stressgen Biotechnologies Corp published on Stockchase.

Is Stressgen Biotechnologies Corp a good investment or a top pick?

Stressgen Biotechnologies Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for Stressgen Biotechnologies Corp.

Why is Stressgen Biotechnologies Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Stressgen Biotechnologies Corp worth watching?

In the last year 0 stock analysts on Stockchase covered Stressgen Biotechnologies Corp. The stock is worth watching.

What is Stressgen Biotechnologies Corp stock price?

On , Stressgen Biotechnologies Corp (SSB-T) stock closed at a price of $.

Your Watchlist

Add stocks to watchlist to monitor them daily and get important alerts.

Get Access To Watchlist

Latest Buy Signals

MATR-TMATTR CORP
MATTR CORP
$13.11
0.01 (0.08%)
DOL-TDollarama Inc.
Dollarama Inc.
$149.66
2.47 (1.62%)
NTR-TNutrien Ltd.
Nutrien Ltd.
$68.14
1.05 (1.52%)
SMAX-THamilton US Equity Yield Maximizer ETF
Hamilton US Equity Yield Maximizer ETF
$20.29
-0.03 (-0.15%)
TLT-QiShares 20+ Year Treasury Bond ETF
iShares 20+ Year Treasury Bond ETF
$93.37
-0.50 (-0.54%)
Advertising

Today's Top Picks

META-QMeta Platforms, Inc.
Meta Platforms, Inc.
$603.88
11.05 (1.80%)
PFE-NPfizer Inc
Pfizer Inc
$25.72
-0.11 (-0.41%)
ATRL-TAtkinsRealis Group
AtkinsRealis Group
$74.77
-0.88 (-1.19%)
NFLX-QNetflix Inc.
Netflix Inc.
$892.20
-5.54 (-0.62%)
MFC-TManulife Financial
Manulife Financial
$45.16
-0.21 (-0.47%)

Popular Articles

Questrade Review: Pros & Cons of Trading with Questrade Canada (2021) Steady Eddys: 3 Stable Stocks Between Safety and Risk: 3 Safe and Gambling Stocks 3 Oversold Stocks to Take Advantage of 5 ETFs for Index Investing

Latest Sell Signals

DOL-TDollarama Inc.
Dollarama Inc.
$149.66
2.47 (1.62%)
MKP-TMCAN Mortgage Corp
MCAN Mortgage Corp
$19.53
-0.02 (-0.10%)
IBIT-QiShares Bitcoin ETF
iShares Bitcoin ETF
$54.30
-0.18 (-0.33%)
HPYT-THarvest Premium Yield Treasury ETF
Harvest Premium Yield Treasury ETF
$10.43
-0.04 (-0.38%)
BNS-TBank of Nova Scotia
Bank of Nova Scotia
$77.20
-2.59 (-3.47%)

Most Recent Experts

Zechner

John Zechner

J. Zechner & Assoc

Berman

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Stockchase

Stockchase Insights

5i Research

Cieszynski

Colin Cieszynski

SIA Wealth Management

Murray

Jamie Murray

Murray Wealth Group

Advertising
Advertising
logoTop pickslogoStockslogoRecentlogoWatchlist
© Stockchase Inc.